AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

LON:THRLTarget Healthcare REIT Share Price, Forecast & News

GBX 105
+2.60 (+2.54 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
102.19
Now: GBX 105
105.60
50-Day Range
90.20
MA: GBX 101.78
110.60
52-Week Range
1.05
Now: GBX 105
124.50
Volume1.18 million shs
Average Volume220,784 shs
Market Capitalization£480.36 million
P/E Ratio13.46
Dividend Yield7.06%
BetaN/A
Target Healthcare REIT Limited is a closed-ended property investment company. The Company's investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long leasehold care homes that are let to care home operators, and other healthcare assets in the United Kingdom. The Company pursues its objective by investing in a portfolio of care homes, in the United Kingdom, that are let to care home operators on repairing and insuring leases. Its portfolio consists of approximately 50 properties. The Company's investment manager is Target Advisers LLP (Target). Target is a provider of advisory and property management services to the healthcare investment sector.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 2.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.71 out of 5 stars


Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorFinance
CUSIPN/A
CIKN/A
Phone+44-131-6252951

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£38.94 million
Cash FlowGBX 7.08 per share
Book ValueGBX 108 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£480.36 million
Next Earnings DateN/A
OptionableNot Optionable

Receive THRL News and Ratings via Email

Sign-up to receive the latest news and ratings for THRL and its competitors with MarketBeat's FREE daily newsletter.

Target Healthcare REIT (LON:THRL) Frequently Asked Questions

How has Target Healthcare REIT's stock been impacted by COVID-19 (Coronavirus)?

Target Healthcare REIT's stock was trading at GBX 111 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, THRL shares have decreased by 5.4% and is now trading at GBX 105. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Target Healthcare REIT?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Target Healthcare REIT in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Target Healthcare REIT.

How often does Target Healthcare REIT pay dividends? What is the dividend yield for Target Healthcare REIT?

Target Healthcare REIT declared a dividend on Tuesday, April 21st. Stockholders of record on Thursday, May 7th will be given a dividend of GBX 1.67 per share on Friday, May 29th. This represents a dividend yield of 1.58%. The ex-dividend date of this dividend is Thursday, May 7th. The official announcement can be viewed at this link. View Target Healthcare REIT's dividend history.

What price target have analysts set for THRL?

1 Wall Street analysts have issued twelve-month price objectives for Target Healthcare REIT's shares. Their forecasts range from GBX 130 to GBX 130. On average, they expect Target Healthcare REIT's stock price to reach GBX 130 in the next twelve months. This suggests a possible upside of 23.8% from the stock's current price. View analysts' price targets for Target Healthcare REIT.

Has Target Healthcare REIT been receiving favorable news coverage?

News headlines about THRL stock have been trending positive recently, InfoTrie Sentiment Analysis reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Target Healthcare REIT earned a media sentiment score of 2.8 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutTarget Healthcare REIT.

Who are some of Target Healthcare REIT's key competitors?

What other stocks do shareholders of Target Healthcare REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Target Healthcare REIT investors own include Cambian Group (CMBN), Realty Income (O), Empiric Student Property (ESP), BHP Group (BHP), Black Box (BBOX), Bayer (BAYN), Basf (BASFY), Bank of America (BAC), Boeing (BA) and Adtalem Global Education (ATGE).

Who are Target Healthcare REIT's key executives?

Target Healthcare REIT's management team includes the following people:
  • Mr. Kenneth Macangus MacKenzie MA CA, Chief Exec. Officer
  • Mr. Gordon Bland BAcc CA, Fin. Director
  • Mr. John Flannelly BAcc FCA, Head of Investment - Target Advisers LLP
  • Mr. Andrew Brown, Head of Healthcare - Target Advisers LLP
  • Mr. Donald Campbell, Head of Tax

What is Target Healthcare REIT's stock symbol?

Target Healthcare REIT trades on the London Stock Exchange (LON) under the ticker symbol "THRL."

How do I buy shares of Target Healthcare REIT?

Shares of THRL and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Target Healthcare REIT's stock price today?

One share of THRL stock can currently be purchased for approximately GBX 105.

How big of a company is Target Healthcare REIT?

Target Healthcare REIT has a market capitalization of £480.36 million and generates £38.94 million in revenue each year.

What is Target Healthcare REIT's official website?

The official website for Target Healthcare REIT is www.targethealthcarereit.co.uk.

How can I contact Target Healthcare REIT?

Target Healthcare REIT's mailing address is Ordnance House, 31 Pier Road, SAINT HELIER, JE4 8PW, Jersey. The company can be reached via phone at +44-131-6252951.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.